Page last updated: 2024-09-04

torcetrapib and Hypertriglyceridemia

torcetrapib has been researched along with Hypertriglyceridemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brousseau, M; Honma, W; Iimura, A; Imase, H; Iwaki, Y; Kawanami, T; LaSala, D; Liang, G; Mitani, H; Mogi, M; Nonomura, K; Ohmori, O; Pan, M; Rigel, DF; Umemura, I; Yamada, K; Yasoshima, K; Zhu, G1
El Harchaoui, K; Kastelein, JJ; Stroes, ES; van der Steeg, WA1

Reviews

1 review(s) available for torcetrapib and Hypertriglyceridemia

ArticleYear
The role of CETP inhibition in dyslipidemia.
    Current atherosclerosis reports, 2007, Volume: 9, Issue:2

    Topics: Amides; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Dyslipidemias; Esters; Female; Humans; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Male; Quinolines; Sulfhydryl Compounds

2007

Other Studies

1 other study(ies) available for torcetrapib and Hypertriglyceridemia

ArticleYear
Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma.
    Journal of medicinal chemistry, 2017, 10-26, Volume: 60, Issue:20

    Topics: Aged; Animals; Chick Embryo; Cholesterol Ester Transfer Proteins; Humans; Hypertriglyceridemia; Male; Mesocricetus; Piperidines; Rats; Structure-Activity Relationship

2017